Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2011 May 11;2011(5):CD001935.
doi: 10.1002/14651858.CD001935.pub3.

Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children

Sharon A Simpson  1 , Ruth Lewis, Judith van der Voort, Christopher C Butler
Affiliations
Meta-Analysis

Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children

Sharon A Simpson et al. Cochrane Database Syst Rev. .

Abstract

Background: Otitis media with effusion (OME) is common and may cause hearing loss with associated developmental delay. Treatment remains controversial.

Objectives: To examine the evidence for treating children with hearing loss associated with OME with systemic or topical intranasal steroids.

Search strategy: We searched the Cochrane ENT Group Trials Register; CENTRAL; PubMed; EMBASE; CINAHL; Web of Science; BIOSIS Previews; Cambridge Scientific Abstracts; mRCT and additional sources for published and unpublished trials. The date of the most recent search was 26 August 2010.

Selection criteria: Randomised controlled trials of oral and topical intranasal steroids, either alone or in combination with another agent such as an oral antibiotic. We excluded publications in abstract form only; uncontrolled, non-randomised or retrospective studies; and studies reporting outcomes by ears (rather than children).

Data collection and analysis: The authors independently extracted data from the published reports using standardised data extraction forms and methods. We assessed the quality of the included studies using the Cochrane 'Risk of bias' tool. We expressed dichotomous results as a risk ratio (RR) and continuous data as weighted mean difference (WMD), both with 95% confidence intervals (CI). Where feasible we pooled studies using a random-effects model and performed tests for heterogeneity between studies. In trials with a cross-over design, we did not use post cross-over treatment data.

Main results: We included 12 medium to high-quality studies with a total of 945 participants. No study documented hearing loss associated with OME prior to randomisation. The follow-up period was generally limited, with only one study of intranasal steroid reporting outcome data beyond six months. There was no evidence of benefit from steroid treatment (oral or topical) in terms of hearing loss associated with OME. Pooled data using a fixed-effect model for OME resolution at short-term follow up (< 1 month) showed a significant effect of oral steroids compared to control (RR 4.48; 95% CI 1.52 to 13.23; Chi² 2.75, df = 2, P = 0.25; I² = 27%). Oral steroids plus antibiotic also resulted in an improvement in OME resolution compared to placebo plus antibiotic at less than one month follow up, using a random-effects model (RR 1.99; 95% CI 1.14 to 3.49; five trials, 409 children). However, there was significant heterogeneity between studies (P < 0.01, I² = 69%). There was no evidence of beneficial effect on OME resolution at greater than one month follow up with oral steroids (used alone or with antibiotics) or intranasal steroids (used alone or with antibiotics) at any follow-up period. There was also no evidence of benefit from steroid treatment (oral or topical) in terms of symptoms.

Authors' conclusions: While oral steroids, especially when used in combination with an oral antibiotic, lead to a quicker resolution of OME in the short term, there is no evidence of longer-term benefit and no evidence that they relieve symptoms of hearing loss. We found no evidence of benefit from treatment of OME with topical intranasal steroids, alone or in combination with an antibiotic, either at short or longer-term follow up.

PubMed Disclaimer

Conflict of interest statement

None known.

Figures

1
1
'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
2
2
'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Oral steroids versus control, Outcome 1 Hearing loss at six weeks (hearing not improved by at least 10 dB in either ear).
1.2
1.2. Analysis
Comparison 1 Oral steroids versus control, Outcome 2 OME resolution (two weeks).
1.3
1.3. Analysis
Comparison 1 Oral steroids versus control, Outcome 3 OME resolution (four to six weeks).
2.1
2.1. Analysis
Comparison 2 Oral steroids plus antibiotic versus control plus antibiotic, Outcome 1 Hearing loss at two months (at least some conductive hearing loss).
2.2
2.2. Analysis
Comparison 2 Oral steroids plus antibiotic versus control plus antibiotic, Outcome 2 OME resolution (seven to 28 days).
2.3
2.3. Analysis
Comparison 2 Oral steroids plus antibiotic versus control plus antibiotic, Outcome 3 OME resolution (one to two months).
2.4
2.4. Analysis
Comparison 2 Oral steroids plus antibiotic versus control plus antibiotic, Outcome 4 Mild to moderate adverse effects at two weeks to six months.
3.1
3.1. Analysis
Comparison 3 Intranasal steroids versus control, Outcome 1 Audiometry failing at nine months (audiometry sweep at 25 dB HL, fail on more than two out of five frequencies in both ears).
3.2
3.2. Analysis
Comparison 3 Intranasal steroids versus control, Outcome 2 Median days with hearing loss (three months).
3.3
3.3. Analysis
Comparison 3 Intranasal steroids versus control, Outcome 3 OME resolution (three weeks).
3.4
3.4. Analysis
Comparison 3 Intranasal steroids versus control, Outcome 4 OME resolution (three months).
3.5
3.5. Analysis
Comparison 3 Intranasal steroids versus control, Outcome 5 OME resolution (nine months).
3.6
3.6. Analysis
Comparison 3 Intranasal steroids versus control, Outcome 6 Minor adverse effects at three months.
4.1
4.1. Analysis
Comparison 4 Topical intranasal steroid plus oral antibiotic versus control plus antibiotic or antibiotic alone, Outcome 1 OME resolution (three months).
4.2
4.2. Analysis
Comparison 4 Topical intranasal steroid plus oral antibiotic versus control plus antibiotic or antibiotic alone, Outcome 2 Symptom score at three months.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Berman 1990 {published data only}
    1. Berman S, Grose K, Nuss R, Huber‐Navin C, Roark R, Gabbard SA, et al. Management of chronic middle ear effusion with prednisone combined with trimethoprim‐sulfamethoxazole. Pediatric Infectious Disease Journal 1990;9(8):533‐8. - PubMed
Giebink 1990 {published data only}
    1. Giebink GC, Batalden PB, Le CT, Russ JN, Knox JK, Anderson RS, et al. Randomized controlled trial comparing trimethoprim‐sulfamethoxazole, prednisone, ibuprofen, and no treatment in chronic otitis media with effusion. Lim DJ, Bluestone CD, Klein JO, Nelson JD, editor(s). Recent Advances in Otitis Media: IVth International Symposium on Otitis Media with Effusion. Philadelphia: B.C. Decker Company, 1988:240‐4.
    1. Giebink GS, Batalden PB, Le CT, Lassman FM, Buran DJ, Seltz AE. A controlled trial comparing three treatments for chronic otitis media with effusion. Pediatric Infectious Disease Journal 1990;9(1):33‐40. - PubMed
Hemlin 1997 {published data only}
    1. Hemlin C, Carenfelt C, Papatziamos G. Single dose of betamethasone in combined medical treatment of secretory otitis media. Annals of Otology Rhinology and Laryngology 1997;106:359‐63. - PubMed
Lambert 1986 {published data only}
    1. Lambert PR. Oral steroid therapy for chronic middle ear perfusion: a double‐blind crossover study. Otolaryngology ‐ Head and Neck Surgery 1986;95:193‐9. - PubMed
Macknin 1985 {published data only}
    1. Maknin ML, Jones PK. Oral dexamethasone for treatment of persistent middle ear effusion. Pediatrics 1985;75:329‐35. - PubMed
Mandel 2002 {published data only}
    1. Mandel EM, Casselbrant ML, Rockette HE, Fireman P, Kurs‐Lasky M, Bluestone CD. Systemic steroid for chronic otitis media with effusion in children. Pediatrics 2002;110(6):1071‐80. - PubMed
Niederman 1984 {published data only}
    1. Niederman LG, Walter‐Bucholtz V, Jabalay T. A comparative trial of steroids versus placebos for treatment of chronic otitis media with effusion. Recent Advances in Otitis Media with Effusion. Philadelphia: B.C. Decker Inc, 1984:273‐5.
Podoshin 1990 {published data only}
    1. Podoshin L, Fradis M, Ben‐David Y, Faraggi D. The efficacy of oral steroids in the treatment of persistent otitis media with effusion. Archives of Otolaryngology ‐ Head and Neck Surgery 1990;116:1404‐6. - PubMed
Schwartz 1980 {published data only}
    1. Schwartz RH, Puglese J, Schwartz DM. Use of a short course of prednisone for treating middle ear effusion; a double‐blind crossover study. Annals of Otology, Rhinology and Laryngology 1980;89(Suppl 68):296‐300. - PubMed
Shapiro 1982 {published data only}
    1. Shapiro GG, Bierman CW, Furukuwa CT, Pierson WE, Berman R, Donaldson J, et al. Treatment of persistent Eustachian tube dysfunction with aerosolised nasal dexamethasone phosphate versus placebo. Annals of Allergy 1982;49:81‐5. - PubMed
Tracy 1998 {published data only}
    1. Tracy JM, Demain JG, Hoffman KM, Goetz DW. Intranasal beclomethasone as an adjunct to treatment of chronic middle ear effusion. Annals of Allergy, Asthma and Immunology 1998;80:198‐206. - PubMed
Williamson 2009 {published data only}
    1. Williamson I, Benge S, Barton S, Petrou S, Letley L, Fasey N, et al. A double‐blind randomised placebo‐controlled trial of topical nasal steroids in 4‐11 year old children with persistent bilateral otitis media with effusion (OME) in primary care. Health Technology Assessment 2009;13(37):1‐144. - PubMed

References to studies excluded from this review

Berman 1987 {published data only}
    1. Berman S, Grose K, Zerbe GO. Medical management of chronic middle‐ear effusion. American Journal of Disease in Children 1987;141:690‐4. - PubMed
Cengel 2006 {published data only}
    1. Cengel S, Akyol MU. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy. International Journal of Pediatric Otorhinolaryngology 2006;70:639‐45. - PubMed
Choung 2008 {published data only}
    1. Choung Y‐H, Shin YR, Choi SJ, Park K, Park HY, Lee JB, et al. Management for the children with otitis media with effusion in the tertiary hospital. Clinical and Experimental Otorhinolaryngology 2008;1(4):201‐5. - PMC - PubMed
Daly 1991 {published data only}
    1. Daly K, Giebink GS, Batalden PB, Anderson RS, Le CT, Lundgren B. Resolution of otitis media with effusion with the use of a stepped treatment regimen of trimethoprim‐sulfamethoxazole and prednisone. Pediatric Infectious Disease Journal 1991;7(7):500‐6. - PubMed
Heary 1990 {published data only}
    1. Heary C, Hokanson J, Ury H, Chang C, Coplan B, Hall M. Lack of efficacy of short‐term prednisone, trimethoprim‐sulfamethoxazole, alone or combined, in persistent otitis media with effusion: season of entry as a possible determinant of outcome. American Journal of Disease in Childhood 1990;144:420.
Ortega del Alamo 2005 {published data only}
    1. Ortega del Alamo P, Rivera Rodríguez T, Sanz Fernández R. The effect of AM3 in the resolution of otitis media with effusion (OME) in paediatric patients. Acta Otorrinolaringologica Espanola 2005;56(1):1‐5. - PubMed
Persico 1978 {published data only}
    1. Persico M, Podoshin L, Fradis M. Otitis media with effusion: a steroid and antibiotic therapeutic trial before surgery. Annals of Otology, Rhinology and Laryngology 1978;87:191‐5. - PubMed
Rosenfeld 1995 {published data only}
    1. Rosenfeld RM. Nonsurgical management of surgical otitis media with effusion. Journal of Laryngology and Otology 1995;109:811‐6. - PubMed
Schwartz 1981 {published data only}
    1. Schwartz RH. Otitis media with effusion: results of treatment with a short course of oral prednisone or intranasal beclomethasone. Otolaryngology ‐ Head and Neck Surgery 1981;89:386‐91. - PubMed
Woodhead 1986 {published data only}
    1. Woodhead JC, Milavetz G, Dusdieker LB, Booth BM, Wilmoth RN. Prednisone treatment of otitis media with effusion. American Journal of Disease in Childhood 1986;140:318.

Additional references

Baggett 1997
    1. Baggett HC, Prazma J, Rose AS, Lane AP, Pillsbury HC. The role of glucocorticoids in endotoxin‐ mediated otitis media with effusion. Archives of Otolaryngology ‐ Head and Neck Surgery 1997;123:41‐6. - PubMed
Bennett 2001
    1. Bennett KE, Haggard MP, Silva PA, Stewart, IA. Behaviour and developmental effects of otitis media with effusion in the teens. Archives of Disease in Childhood 2001;85:91‐5. - PMC - PubMed
Berman 1994
    1. Berman S, Roark R, Luckey D. Theoretical cost effectiveness of management options for children with persisting middle ear effusion. Pediatrics 1994;93:353‐63. - PubMed
Bluestone 1988
    1. Bluestone CD, Klein JO. Otitis media in infants and children. Philadelphia: W.B. Saunders Company, 1988.
Browning 2010
    1. Browning GG, Rovers MM, Williamson I, Lous J, Burton MJ. Grommets (ventilation tubes) for hearing loss associated with otitis media with effusion in children. Cochrane Database of Systematic Reviews 2010, Issue 10. [DOI: 10.1002/14651858.CD001801.pub3] - DOI - PubMed
Chantzi 2005
    1. Chantzi FM, Bairmis T, Papadopoulos NG, Kafetzis DA. Otitis media with effusion: an effort to understand and clarify the uncertainties. Expert Review of Anti‐infective Therapy 2005;3(1):117‐29. - PubMed
Davies 1998
    1. Davies HTO, Crombie IK, Tavakoli M. When can odds ratios mislead?. BMJ 1998;316(7136):989‐91. - PMC - PubMed
Deeks 2008
    1. Deeks JJ, Higgins JPT, Altman DG (editors). Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester, UK: John Wiley & Sons, 2008.
Dempster 1991
    1. Dempster JH, MacKenzie K. Tympanometry in the detection of hearing impairments associated with otitis media with effusion. Clinical Otolaryngology and Allied Sciences 1991;16:157‐9. - PubMed
Dengerink 1984
    1. Dengerink JE, Porter JB. Childrens attitudes towards peers wearing hearing aids. Language, Speech and Hearing Services in Schools 1984;205‐9:15.
Ducharme 2003
    1. Ducharme FM, Chabot G, Polychronakos C, Glorieux F, Mazer B. Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism, bone density, and adrenal function. Pediatrics 2003;111(2):376‐83. - PubMed
Gates 1996
    1. Gates GA. Cost effectiveness considerations in otitis media treatment. Otolaryngology ‐ Head and Neck Surgery 1996;114:525‐30. - PubMed
Gouma 2010
    1. Gouma P, Mallis A, Daniilidis V, Gouveris H, Armenakis N, Naxakis S. Behavioural trends in young children with conductive hearing loss: a case‐control study. European Archives of Oto‐Rhino‐Laryngology 2010; Vol. 268, issue 1:63‐6. - PubMed
Griffin 2006
    1. Griffin G, Flynn CA, Bailey RE, Schultz JK. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858.CD003423.pub2] - DOI - PubMed
Haddard 1998
    1. Haddad J, Egusa K, Takoudes TG. Effects of 21‐aminosteroid U‐74389G on acute otitis media in a guinea pig model. Otolaryngology ‐ Head and Neck Surgery 1998;118:44‐8. - PubMed
Haggard 1991
    1. Haggard M, Hughes E. Screening children's hearing: a review of the literature and the implications for otitis media. London: HMSO 1991.
Handbook 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
HES 2010
    1. Hospital Episode Statistics (HES online). http://www.hesonline.nhs.uk/ (accessed 23 February 2010).
Kazanas 1994
    1. Kazanas SG, Maw R. Tympanometry, stapedius reflex and hearing impairment in children with otitis media with effusion. Acta Oto‐Laryngologica 1994;114:410‐4. - PubMed
Lanphear 1997
    1. Lanphear BP, Byrd RS, Auinger P, Hall CB. Increasing prevalence of recurrent otitis media among children in the United States. Pediatrics 1997;99:468(a). - PubMed
Lous 1995a
    1. Lous J. Otitis media and reading achievement: a review. International Journal of Pediatric Otorhinolaryngology 1995;32:105‐21. - PubMed
Lous 1995b
    1. Lous J. Secretory otitis media in schoolchildren: is screening for secretory otitis media advisable?. Danish Medical Bulletin 1995;42(1):71‐99. - PubMed
MRC Multi‐Centre Otitis Media Study Group 1999
    1. MRC Multi‐Centre Otitis Media Study Group. Sensitivity, specificity and predictive value of tympanometry in predicting a hearing impairment in otitis media with effusion. Clinical Otolaryngology and Allied Sciences 1999;24(4):294‐300. - PubMed
MRC Multi‐Centre Otitis Media Study Group 2001
    1. MRC Multi‐Centre Otitis Media Study Group. Risk Factors for Persistence of Bilateral Otitis Media with Effusion. Clinical Otolaryngology 2001;26:147‐56. - PubMed
NICE 2008
    1. National Institute for Health and Clinical Excellence. NICE Guideline 60: Surgical management of otitis media with effusion in children. London: National Institute for Health and Clinical Excellence, February 2008 (www.nice.org.uk/nicemedia/pdf/CG60NICEguideline.pdf).
NIH 2007
    1. EPR 3. Expert panel report 3: Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 07‐4051. Bethesda, MD: U.S. Department of Health and Human Services; National Institutes of Health; National Heart, Lung, and Blood Institute; National Asthma Education and Prevention Program, 2007 (available at http://www.nhlbi.nih.gov/guidelines/asthma/asthmafullrpt.pdf).
Nuss 1990
    1. Nuss R, Berman S. Medical management of persistent middle ear effusion. American Journal of Asthma and Allergy for Pediatricians 1990;4:17‐22.
RevMan 2011 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Rosenfeld 1991
    1. Rosenfeld RM, Mandel EM, Bluestone CD. Systemic steroids for otitis media with effusion in children. Archives of Otolaryngology ‐ Head and Neck Surgery 1991;117:984‐9. - PubMed
Rosenfeld 1992
    1. Rosenfeld RM. New concepts for steroid use in otitis media with effusion. Clinical Pediatrics 1992;31(10):615‐21. - PubMed
Schappert 1992
    1. Schappert SM. Office Visits for Otitis Media: United States, 1975‐90. Advance data from vital and health statistics; no 214. Hyattsville, Maryland: National Center for Health Statistics, 1992. - PubMed
Stool 1994
    1. Stool SE, Berg AO, Berman S, et al. Otitis media with effusion in young children. Clinical practice guideline. Number 12. Agency for Health Care Policy and Research, Public Health Services, US Department of Health and Human Services 1994.
Tan 1997
    1. Tan G, Escoubet B, Abbeele G, Friedlander P, Huy TB, Herman P. Modulation of middle ear epithelial function by steroids: clinical relevance. Acta Otolaryngologica (Stockholm) 1997;117:284‐8. - PubMed
Williams 1993
    1. Williams RL, Chalmers TC, Stange KC, Chalmers FT, Bowlin SJ. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. JAMA 1993;270:1344‐51. - PubMed
Wu 2008
    1. Wu CT, Tsai SC, Lin JJ, Hsia SH. Disseminated varicella infection in a child receiving short‐term steroids for asthma. Pediatric Dermatology 2008;25(4):484‐6. - PubMed
Yaman 2008
    1. Yaman H, Ozturk K, Uyar Y, Gurbilek M. Effectiveness of corticosteroids in otitis media with effusion: an experimental study. Journal of Laryngology and Otology 2008;122(1):25‐30. - PubMed
Yusuf 1985
    1. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Progress in Cardiovascular Diseases 1985;27:335‐71. - PubMed
Zielhuis 1990
    1. Zielhuis GA, Rach GH, Bosch AV, Broek PV. The prevalence of otitis media with effusion: a critical review of the literature. Clinical Otolaryngology 1990;15:283‐8. - PubMed

References to other published versions of this review

Butler 2001
    1. Butler CC, Voort JH. Steroids for otitis media with effusion: a systematic review. Archives of Pediatrics and Adolescent Medicine 2001;155(6):641‐7. - PubMed
Butler 2002
    1. Butler CC, Voort JH. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database of Systematic Reviews 2002, Issue 4. [DOI: 10.1002/14651858.CD001935.pub2] - DOI - PubMed
Thomas 2006
    1. Thomas CL, Simpson S, Butler CC, Voort JH. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD001935.pub2] - DOI - PubMed

MeSH terms